首页> 美国政府科技报告 >Antibody Specificity to Oncogene-Derived Peptides for Breast Cancer Detection
【24h】

Antibody Specificity to Oncogene-Derived Peptides for Breast Cancer Detection

机译:用于乳腺癌检测的癌基因衍生肽的抗体特异性

获取原文

摘要

This report describes the work carried out on the specificity of four oncogenicpeptide-monoclonal antibody interactions. Monoclonal antibody 172-12A4, which was raised against a peptide from v-erbB was assayed by ELISA with a set of 152 substitution analogs of the antigenic determinant to yield a fingerprint profile of this antigen-antibody interaction. A number of peptide libraries have also been screened and the deconvolution of individual sequences is ongoing. Peptide libraries have been screened against mAb 121-15B10, which was raised against a peptide from v-fes and is homologous with the v-erbB peptide. Peptides with nanomolar affinities have been identified. The antigenic determinants for six antibodies against two different oncogenic peptides were located using omission analogs. Substitution analogs are being synthesized to identify the amino acid specificities of each of these antibodies. Peptide libraries were also screened against these two peptide-antibody interactions, and the deconvolution process is ongoing. The understanding of antibody specificity at the amino acid level will help in the development of these antibodies as early diagnostics for breast cancer.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号